Off-label use of medicines: an agenda for post-Covid-19

AUTORE: Avv. Carlo Piria

In order to deal with the Covid-19 pandemic, AIFA has taken some decisions concerning the “648 list”, the list of medicines established by Law no. 648/1996, which includes, among others, off-label medicines, i.e. medicines that may be used outside their authorised indications.